Vitamin C, doxycycline, and azithromycin (VDA) targeted changes in cellular senescence-related genes in human adipose-derived mesenchymal stem cells

Document Type : Original Article

Authors

1 Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran

2 Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

3 Department of Clinical Biochemistry, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

4 Cancer and Immunology Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

5 Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

6 Zoonosis Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

10.22038/ijbms.2024.78183.16905

Abstract

Objective(s): Adipose-derived Mesenchymal stem cells (ASCs) have garnered attention for their regenerative potential; therefore, their cellular senescence-related gene expression remains crucial in therapeutic contexts. Nowadays, combination therapies have shown promising results in reducing senescent cells. This study investigated the effects of vitamin C, doxycycline, and azithromycin co-treatment on the key cellular senescence-associated genes in ASCs.
Materials and Methods: Human ASCs were cultured and treated for 24 hr with vitamin C, doxycycline, azithromycin, and a combination of three drugs. Total RNAs were extracted, and the expression of p21, p16, Nanog, Oct4, and Sox2 genes was assessed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Additionally, cell cycle alterations were analyzed via flow cytometry after treatment with these compounds. 
Results: Notably, vitamin C treatment resulted in a significant down-regulation of p21 gene expression (P<0.01), implicating the potential role of vitamin C in promoting cell cycle progression. Doxycycline treatment led to a significant up-regulation of p21 and p16 gene expression (P<0.05), as it has previously been shown to induce cell cycle arrest. Similarly, azithromycin treatment predominantly increased p21 expression (P<0.05). Besides, cell cycle analysis revealed that each compound had changed the distribution of cells across different phases of the cell cycle. 
Conclusion: The combined use of all three drugs yielded intricate interactions, suggesting a complex yet promising approach to future research. According to our findings, the major difference in the combination drug-treated group (VDA) can be explained by the neutralizing effect of these three components in the environment.

Keywords

Main Subjects


1. Dodig S, Čepelak I, Pavić I. Hallmarks of senescence and aging. Biochem Med 2019; 29:483-497.
2. Shakeri H, Lemmens K, Gevaert AB, De Meyer GR, Segers VF. Cellular senescence links aging and diabetes in cardiovascular disease. Am J Physiol Heart Circ Physiol 2018; 315:H448-H462.
3.Campisi J, Andersen JK, Kapahi P, Melov S, editors. Cellular senescence: A link between cancer and age-related degenerative disease? Semin Cancer Biol 2011:21:354-359.
4. Kumari R, Jat P. Mechanisms of cellular senescence: Cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol 2021; 9:1-24.
5. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol 2013; 10:274-283.
6. Li Y, Wu Q, Wang Y, Li L, Bu H, Bao J. Senescence of mesenchymal stem cells. Int J Mol Med 2017; 39:775-782.
7. Kapetanos K, Asimakopoulos D, Christodoulou N, Vogt A, Khan W. Chronological age affects MSC senescence in vitro—a systematic review. Int J Mol Sci 2021; 22:7945-7959.
8. DiMarino AM, Caplan AI, Bonfield TL. Mesenchymal stem cells in tissue repair. Front Immunol 2013; 4:201-209.
9. Meirelles LdS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119:2204-2213.
10. Andrzejewska A, Lukomska B, Janowski M. Concise review: Mesenchymal stem cells: From roots to boost. Stem Cells 2019; 37:855-864.
11. Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, et al. Mesenchymal stem cell‐based therapy: A new paradigm in regenerative medicine. J Cell Mol Med 2009; 13:4385-4402.
12. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 2008; 314:1937-1944.
13. Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 2010; 16:445-453.
14. Passos JF, Nelson G, Wang C, Richter T, Simillion C, Proctor CJ, et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol 2010; 6:347-360.
15. Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer 2012; 130:1715-1725.
16. Cho Y-Y, Kim DJ, Lee HS, Jeong C-H, Cho E-J, Kim M-O, et al. Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells. PLoS One 2013; 8:e57172.
17. Lu Y, Qu H, Qi D, Xu W, Liu S, Jin X, et al. OCT4 maintains self-renewal and reverses senescence in human hair follicle mesenchymal stem cells through the downregulation of p21 by DNA methyltransferases. Stem Cell Res Ther 2019; 10:1-16.
18. Chen X, Xu H, Hou J, Wang H, Zheng Y, Li H, et al. Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. Aging (Albany NY) 2020; 12:242-259.
19. Zhang D-y, Wang H-j, Tan Y-z. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS One 2011; 6:e21397.
20. Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: Past, present, and future. Stem Cell Res Ther 2019; 10:1-22.
21. Zhu M, Meng P, Ling X, Zhou L. Advancements in therapeutic drugs targeting of senescence. Ther Adv Chronic Dis 2020; 11:2040622320964125.
22. Carr AC, Maggini S. Vitamin C and immune function. Nutrients 2017; 9:1211-1235.
23. Kim J-E, Jin D-H, Lee S-D, Hong S-W, Shin J-S, Lee S-K, et al. Vitamin C inhibits p53-induced replicative senescence through suppression of ROS production and p38 MAPK activity. Int J Mol Med 2008; 22:651-655.
24. Li Y, Zhang W, Chang L, Han Y, Sun L, Gong X, et al. Vitamin C alleviates aging defects in a stem cell model for Werner syndrome. Protein Cell 2016; 7:478-488.
25. Ghasemi K, Ghasemi K. A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies. Eur J Pharmacol 2022; 916:174593.
26. Henehan M, Montuno M, De Benedetto A. Doxycycline as an anti‐inflammatory agent: updates in dermatology. J Eur Acad Dermatol Venereol 2017; 31:1800-1808.
27. Sargiacomo C, Sotgia F, Lisanti MP. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging (Albany NY) 2020; 12:6511-6517.
28. Li X, Khan D, Rana M, Hänggi D, Muhammad S. Doxycycline attenuated ethanol-induced inflammaging in endothelial cells: Implications in alcohol-mediated vascular diseases. Antioxidants 2022; 11:2413-2432.
29. Bakheit AH, Al-Hadiya BM, Abd-Elgalil AA. Azithromycin. Profiles Drug Subst Excip Relat Methodol 2014; 39:1-40.
30. Jiang X, Baucom C, Elliott RL. Mitochondrial toxicity of azithromycin results in aerobic glycolysis and DNA damage of human mammary epithelia and fibroblasts. Antibiotics 2019; 8:110-126.
31. Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2006; 350:977-982.
32. Qiu Z, Jia J, Zou H, Ao Y, Liu B, Wang Z. Targeting senescent cell clearance: An approach to delay aging and age-associated disorders. Transl Med Aging 2021; 5:1-9.
33. Ozsvari B, Nuttall JR, Sotgia F, Lisanti MP. Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts. Aging (Albany NY) 2018; 10:3294.
34. Fiorillo M, Tóth F, Sotgia F, Lisanti MP. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs). Aging (Albany NY) 2019; 11:2202.
35. De Francesco EM, Bonuccelli G, Maggiolini M, Sotgia F, Lisanti MP. Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget 2017; 8:67269.
36. Ghorbani A, Jalali SA, Varedi M. Isolation of adipose tissue mesenchymal stem cells without tissue destruction: A non-enzymatic method. Tissue Cell 2014; 46:54-58.
37. Salimiyan S, Mohammadi M, Aliakbari S, Kazemi R, Amini AA, Rahmani MR. Hydrocortisone long-term treatment effect on immunomodulatory properties of human adipose-derived mesenchymal stromal/stem cells. J Interferon Cytokine Res 2022; 42:72-81.
38. Bellagamba BC, Abreu BRRd, Grivicich I, Markarian CF, Camassola M, Nardi NB, Dihl RR. Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro. Genet Mol Biol 2016; 39:129-134.
39. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3:1101-1108.
40. Son K, Fujioka S, Iida T, Furukawa K, Fujita T, Yamada H, et al. Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer Res 2009; 29:3995-4003.
41. Chang M-Y, Rhee Y-H, Yi S-H, Lee S-J, Kim R-K, Kim H, et al. Doxycycline enhances survival and self-renewal of human pluripotent stem cells. Stem Cell Reports 2014; 3:353-364.
42. Lin T, Pajarinen J, Kohno Y, Nabeshima A, Lu L, Nathan K, et al. Increased NF-κB activity in osteoprogenitor-lineage cells impairs the balance of bone versus fat in the marrow of skeletally mature mice. Regen Eng Transl Med 2020; 6:69-77.
43. Ribeiro CMP, Hurd H, Wu Y, Martino ME, Jones L, Brighton B, et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One 2009; 4:e5806.
44. Stellari FF, Sala A, Donofrio G, Ruscitti F, Caruso P, Topini TM, et al. Azithromycin inhibits nuclear factor‐κB activation during lung inflammation: An in vivo imaging study. Pharmacol Res Perspect 2014; 2:e00058.
45. Jeong JH, Kim MB, Kim C, Hwang JK. Inhibitory effect of vitamin C on intrinsic aging in human dermal fibroblasts and hairless mice. Food Sci Biotechnol 2018; 27:555-564.